Mucormycosis associated with COVID-19 in two kidney transplant patients

Carolt Arana; Rafael E Cuevas Ramírez; Marc Xipell; Joaquim Casals; Asunción Moreno; Sabina Herrera; Marta Bodro; Frederic Cofan; Fritz Diekmann; Núria Esforzado

doi:10.1111/tid.13652

Mucormycosis associated with COVID-19 in two kidney transplant patients

Transpl Infect Dis. 2021 Aug;23(4):e13652. doi: 10.1111/tid.13652. Epub 2021 Jun 13.

Affiliations

¹ Department of Nephrology, Fundació Puigvert, Barcelona, Spain.
² Department of Nephrology and Renal Transplantation, Hospital Clinic de Barcelona, Barcelona, Spain.
³ Department of Infectious Diseases, Hospital Clinic Barcelona, Barcelona, Spain.

Abstract

Coronavirus disease 2019 (COVID-19) predisposes patients to bacterial and fungal superinfections due to the impairment of the immunological system. Among the associated opportunistic fungal infections, mucormycosis is one of the least frequent but with the highest mortality. We describe two cases of mucormycosis in two kidney transplant recipients, while they were hospitalized for SARS-CoV-2 pneumonia, with rhinosinusal and musculoskeletal involvement, respectively.

Keywords: COVID-19; kidney transplant; mucormycosis; transplantation.

Publication types

Case Reports

MeSH terms

COVID-19*
Humans
Kidney Transplantation* / adverse effects
Mucormycosis* / diagnosis
Mucormycosis* / drug therapy
SARS-CoV-2
Transplant Recipients